2. BIOPHARMACEUTICAL
Korea
Where Success Knows No Limits
2
Index
1.IndustryOverview 3
2.CompetitiveStanding andOutlook 9
3.GovernmentPolicies 14
4.StatusofForeignDirectInvestment 15
3. Market size & production trends
3
Recent developments in Korea’s pharmaceutical industry
Unit : KRW mn.
13,893,810
14,788,387
15,569,588 15,440,251
15,560,663
16,191,845
16,957,675
17,970,026
18,908,439 18,943,812
18,980,003 19,029,152
2008 2009 2010 2011 2012 2013
Production
Market size
4. Export & import trends
4
Export & import trends in Korea’s pharmaceutical industry
1,255,891
1,772,242 1,770,059
1,943,493
2,309,534 2,318,522
4,319,756
4,953,881
5,108,911
5,447,053
5,728,874
5,155,829
2008 2009 2010 2011 2012 2013
Export
Import
Source: Korea Health Industry Development Institute (2014), Analysis of Korea’s Pharmaceutical Industry (2013)
Unit : KRW mn.
5. Human resource trends
5
Number of people employed in Korea’s pharmaceutical industry
Korea Health Industry Development Institute (2014), Analysis of Korea’s Pharmaceutical Industry (2013)
75,406
81,204
77,314
74,477
78,259
2008 2009 2010 2011 2012
Unit : People
6. Market size & production trends
6
Market size and production trends of the biotech industry
Source: IMS Health (2012)
2,773,474
5,787,826
6,396,252
7,129,229
7,523,831
4,236,695
4,751,946
5,208,078
5,643,437
5,866,853
2009 2010 2011 2012 2013
Production
Market Size
Unit : KRW mn.
7. Number of biotech companies
7
Changes in number of biotech companies
Source: Biotech Industry Study (2014)
918
276 188 202 247
958
305
204 199
250
971
317
203 199
252
Total Biopharmaceuticals Biochemicals Bioengineered food Others
2011 2012 2013
Unit : Companies
Other
8. Human resource trends
8
Workforce structure of the biotech industry
Unit : People
Source: Biotech Industry Study (2014)
1,030 362 345 359
3,519
1,355 1,298 1,239
6,877
1,937
3,527 3,079
7,043
1,282
2,900
2,045
Biopharmaceuticals biopharmaceuticals Bioengineered food Others
Doctoral degree
Master’s degree
Bachelor’s degree
Other
OtherBiochemicals
9. 9
Size and growth outlook of the global biotech market
Source: IMS Health (2012)
987.2
1,079.00
1,181.50
1,298.4
1,434.70
1,572.40
2010 2011 2012 2013 2014 2015
CAGR: 9.7%
Outlook of the global biotech market
Unit : USD bn.
10. Outlook of the domestic biotech market
10
Korea’s in vitro diagnostic medical device (IVD) market
Source: Ministry of Trade, Industry & Energy, Five-year Plan for Technology Innovation (2013)
2009 2010 2011 2012 2013 2014
Bioelectronics 369 489 553 624 724 840
Bioinformatics & biological
assay
1,406 1,355 1,531 1,730 1,955 2,209
Bio diagnostics
(20% of the diagnostic
test market)
600 690 780 881 996 1,125
Total 2,375 2,534 2,864 3,235 3,675 4,174
Unit : KRW mn.
11. Most promising sector
11
Outlook for the Korean therapeutic antibodies market
Source: Ministry of Trade, Industry & Energy, Five-year Plan for Technology Innovation (2013)
Unit : KRW mn
300
830
3,000
2006 2010 2015
12. Increased R&D investments
12
Unit : KRW million
R&D investments by Korean
pharmaceutical companies
Source: Korea Health Industry Statistics System (KHISS)
578,268
648,362
684,207
813,755
967,239
2008 2009 2010 2011 2012
Korea’s biotech R&D investments
Source: Biotech Industry Study (2014)
Unit : KRW million
9,302
10,079
11,651
2011 2012 2013
13. Increased R&D concentration
13
Unit : %
R&D concentration among Korean pharmaceutical companies
6.24
6.5 6.44
7.41
7.67
2008 2009 2010 2011 2012
14. Govt. efforts in the pharmaceutical industry
2013 - Five-year Comprehensive Plan
treamlined procedures for new drug registration
The PB 300 Project
14
15. 15
Source: Biotech Industry Study (2014)
Unit: KRW 100 mn
2009 2010 2011 CAGR
Government R&D 123,437 137,014 148,902 9.8%
Biotech R&D 20,112 23,252 25,808 13.3%
Biotech R&D as
% of government R&D 16.3% 17.0% 17.3% -
Government efforts in the biotech industry
Government R&D investments by segment
